Trial Site Detail


BEZ235 + MEK162
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting


MD Anderson Cancer Center

1505 Holcombe Blvd.     
Houston , TX 77030


Principal Investigator:
Filip Janku, MD
Filip Janku, MD 713-563-2632
Activation Status of this Site:
Notes about this Site:
MD Anderson Cancer Center Website:



Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.